Interestingly, somatic pathogenic NF1 variants may contribute to endocrine resistance in advanced breast cancer; however, their precise clinical relevance in individuals with germline pathogenic NF1 variants remains to be fully elucidated [101]. The gene discussed is NF1; the disease is breast carcinoma.